What is MGNX's dilution risk score?

MGNX has a latest available DilutionScore record of 43/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for MGNX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for MGNX?

DilutionWatch tracks 25 SEC filing types for MGNX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect MGNX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For MGNX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for MGNX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for MGNX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

MGNX Dilution Risk Score: 43/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

40

💰 Cash Runway

65

📊 Float Risk

10

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 7%

💰 Capital Raise model 15%

• Under 12 months cash (10mo)

🔔 Track MGNX — Get forecast alerts →

Market Data

Market Cap$264.42M

Shares Outstanding63.70M

Float55.60M

Cash$113.91M

Debt$36.51M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 20.2% shares (2026Q1 vs prior)

112 institutional holders · 49.16M shares

#1 ARMISTICE CAPITAL, LLC 6.01M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 5.31M shares

#3 RENAISSANCE TECHNOLOGIES LLC 2.96M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.34M

Days to Cover9.3

% of Float13.2%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2013-12-31

4 INSIDER TRANSACTION 2026-02-17

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual MGNX Dilution Snapshot

MacroGenics, Inc. (MGNX) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for MGNX: 4 on 2026-02-17; 4 on 2026-02-17; 4 on 2026-02-17.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

More Research for MGNX

MGNX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

MGNX — MacroGenics, Inc. Dilution Risk Tracker